Spots Global Cancer Trial Database for Compliant Analysis of Patient Samples and Data
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Compliant Analysis of Patient Samples and Data
Official Title: Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies and/or Population-based Analysis
Study ID: NCT04364503
Study Description
Brief Summary: Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Detailed Description: Arm 1 - Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R\&D studies or population-based analysis by LabCorp or affiliates. Arm 2 - Collection of samples and/or data from commercial test patients requiring follow-up or from subjects of scientific interest after informed consent is obtained.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Sequenom, Inc, San Diego, California, United States
Contact Details
Name: Graham P McLennan
Affiliation: Sequenom, Inc.
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
